Kyverna Therapeutics Logo

Kyverna Therapeutics

About Kyverna Therapeutics

Kyverna Therapeutics is a clinical-stage biopharmaceutical firm focusing on cell therapies for autoimmune diseases. They pioneer CAR T-cell therapies, aiming for sustained remission for conditions like multiple sclerosis and lupus nephritis. Their lead candidate, KYV-101, is in clinical trials, with a pipeline of CAR T-cell therapies in autologous and allogeneic formats.

Current Openings

1 Job Opening Found at Kyverna Therapeutics

Executive Director, Regulatory Affairs

Executive Director, Regulatory Affairs

Kyverna Therapeutics

Join Kyverna Therapeutics as an Executive Director of Regulatory Affairs! Lead strategic regulatory initiatives, ensure commercial readiness, and engage with health authorities.